|
Hematology and Hemostasis |
922 |
Leveraging Whole Genome Sequencing data in TOPMed to refine prior GWAS loci and further identify new/novel loci that determine platelet aggregation. |
Rasika Mathias |
|
Hematology and Hemostasis |
16499 |
‘Omic Signatures of Mosaic Chromosomal Alterations (mCA) and Loss of Y (LOY) and Relationship to Cardiovascular Disease in TOPMed |
Laura Raffield |
|
Hematology and Hemostasis |
14911 |
(Breakout) Integrative analysis of multi-omics data for platelet aggregation in GeneSTAR |
Rasika Mathias |
|
Hematology and Hemostasis |
13748 |
(Revised) (Revised) The landscape of chromosomal mosaic events in TOPMed participants and their association with hematological traits. |
Paul Auer |
|
Hematology and Hemostasis |
12031 |
(Revised) Investigating the effect of germ-line structural variants on blood cell traits: the TOPMed whole genome sequencing project |
Paul Auer |
|
Hematology and Hemostasis |
13705 |
(Revised) The landscape of chromosomal mosaic events in TOPMed participants and their association with hematological traits. |
Paul Auer |
|
Hematology and Hemostasis |
15273 |
(Revised) Whole genome sequence analysis of coagulation factor VIII (FVIII) and von Willebrand factor (vWF) across TOPMed studies |
Nicholas Smith |
|
Hematology and Hemostasis |
15814 |
(Revised) Whole genome sequence analysis of D-dimer across TOPMed studies |
Nicholas Smith |
|
Hematology and Hemostasis |
15815 |
(Revised) Whole genome sequence analysis of tissue plasminogen activator (tPA) and plasminogen activator inhibitor (PAI-1) across TOPMed studies |
Nicholas Smith |
|
Hematology and Hemostasis |
7642 |
A family based approach leveraging WGS data to study telomere length in BAGS |
Michelle Daya |
